Japanese AIDS Vaccine To Be Clinically Tested In U.S. In '10 (Japan)
This article was originally published in PharmAsia News
Executive Summary
A Japanese consortium including the University of Tokyo, Dnavec, and the National Institute of Infectious Diseases plans to begin clinical testing of its AIDS vaccine as early as 2010. The consortium hopes to commercialize the vaccine around 2015. The nasal spray vaccine effort will mark the first such testing of a Japanese-developed AIDS vaccine. Researchers expect the vaccine to increase the number of immune cells available to attack cells infected by HIV. The consortium found that HIV did not propagate among 60% of monkeys given the vaccine prior to being exposed to the virus. The International AIDS Vaccine Initiative will organize clinical tests involving several dozen healthy people. If the vaccine's safety and effectiveness are borne out by those tests, larger scale clinical tests will be carried out. (Click here for more - May Require Paid Subscription
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.